Back to Results
First PageMeta Content
Health / Clinical pharmacology / Food and Drug Administration / Therapeutics / United States Public Health Service / Daniel R. Levinson / United States Department of Health and Human Services / Inspector General / Didanosine / Pharmaceutical sciences / Health policy / Pharmacology


Outside Activities of FDA Employees (OEI[removed]; 02/06)
Add to Reading List

Document Date: 2006-02-07 14:38:20


Open Document

File Size: 1,16 MB

Share Result on Facebook

Company

VULNERABILITIES Limited / The Los Angeles Times / /

Country

United States / /

Event

FDA Phase / /

IndustryTerm

legal services / auditing services / /

Organization

U.S. House of Representatives Committee on Energy and Commerce / FDA / Congress / office of Inspector General / National Institute of Health / office of Audit Services / office of Investigations / office of Government Ethics / Food and Drug Administration / Department of Health and Human Services / OFFICE OF INSPECTOR GENERAL RESPONSE While / office of Evaluation and Inspections / office of Evaluation / office of Management / /

Position

supervisor / Counsel / final approving official / EMPLOYEES Daniel R. Levinson Inspector General / Commissioner / EXECUTIVE / C E O / Inspector General / /

Product

HHS-520 / /

PublishedMedium

the FDA review / Public Law / The Los Angeles Times / /

URL

http /

SocialTag